Nice share JP. Agreed.@RaceOncology Hi Daniel,There’s been...

  1. 1,679 Posts.
    lightbulb Created with Sketch. 460
    Nice share JP. Agreed.

    @RaceOncology

    Hi Daniel,

    There’s been persistent discussion among shareholders around a possible trading blackout for RAC staff since mid-2024, with speculation pointing toward regional deal negotiations. While I appreciate there are limits on what can be disclosed, I’d like to raise a broader question around RAC’s communication approach.

    Dimerix (DXB), in a similar position, was able to publicly confirm the existence of non-binding offers well before finalising their regional deals. This helped set expectations, reduced market speculation, and built confidence that management was actively progressing commercial outcomes.

    If RAC is at a comparable stage, what prevents us from making a similar disclosure, something factual and high level, like “RAC is currently engaged in active partnering discussions or reviewing non-binding proposals”? Such a statement wouldn’t compromise negotiations, but it would remove the ambiguity, winks, and nudges that dominate forums right now. More importantly, it would improve transparency and show leadership in communication.

    As a long-term RAC and DXB investor, I ask this constructively and in good faith, how far can we go in updating the market while respecting commercial confidentiality?

    Appreciate any clarity you can provide.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.14
Change
-0.015(1.30%)
Mkt cap ! $197.1M
Open High Low Value Volume
$1.16 $1.16 $1.13 $170.4K 148.8K

Buyers (Bids)

No. Vol. Price($)
1 5868 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.14 2062 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.